Although EPDR1 has been studied in colorectal cancer and is considered a protumor molecule capable of accelerating tumor metastasis (Chu et al, 2018), its function remains controversial, and the specific mechanism underlying its actions is yet to be fully elucidated. Here, EPDR1 is linked to neoplasm.